BCL2 and neoplasm: Earlier studies demonstrated that several BCL-2 inhibitors may stimulate ER stress conditions, including accumulation and aggregation of unfolded and misfolded proteins to manifest their anti-tumor activities (Soderquist R. et al., 2014; Soderquist R. S. et al., 2014).